Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

Details for Australian Patent Application No. 2010239522 (hide)

Owner Theravance, Inc.

Inventors Hughes, Adam; Byun, Daniel; Chen, Yan; Fleury, Melissa; Jacobsen, John R.; Stangeland, Eric L.; Wilson, Richard D.; Yen, Rose

Agent Davies Collison Cave

Pub. Number AU-A-2010239522

PCT Pub. Number WO2010/123766

Priority 61/172,039 23.04.09 US

Filing date 16 April 2010

Wipo publication date 28 October 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/123766 Priority application(s): WO2010/123766

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239526-Method and system for measuring user experience for interactive activities

2010239515-Compositions and methods for treating burns